Nokea
Oral glucose tolerance tests (OGTT) are performed in an overweight person , in whom the disturbed glucose tolerance is now diagnosed for the first time, and in a person with normal body weight who shows normal glucose values after oral glucose intake. Question: Which of the following glucose and insulin values, measured one hour after oral glucose intake, are most consistent with these two people?
- A. Glucose 12 mmol/L, Insulin 60 mU/L ; Glucose 8 mmol/L, Insulin 40 mU/L
- B. Glucose 12 mmol/L, Insulin 10 mU/L ; Glucose 8 mmol/L, Insulin 60 mU/L
- C. Glucose 8 mmol/L, Insulin 60 mU/L ; Glucose 4 mmol/L, Insulin 40 mU/L
- D. Glucose 8 mmol/L, Insulin 10 mU/L ; Glucose 4 mmol/L, Insulin 60 mU/L
Correct Answer: A
Rationale: Overweight with new impaired tolerance high glucose, high insulin as fat resists; normal weight, normal test moderate glucose, steady insulin. Twelve and 60 fit the struggler; 8 and 40 the healthy nurses read this, a chronic resistance tale in numbers.
You may also like to solve these questions
Which ONE of the following is consistent with scarlet fever:
- A. Punctate rash on neck and trunk
- B. Circumoral erythema
- C. Geographic tongue
- D. Only occurs in association with streptococcal pharyngitis
Correct Answer: B
Rationale: Scarlet fever circumoral pallor, not erythema, rash, tongue, strep, peeling fit. Nurses spot this chronic strep face.
Glibenclamide belongs to the class
- A. Sulphonylureas
- B. Thiazolidinediones
- C. Benzoic acid derivatives
- D. Biguanides
Correct Answer: A
Rationale: Glibenclamide's a sulphonylurea pumps insulin from beta cells, a classic diabetes fix. Thiazolidinediones tweak sensitivity, benzoic acids like repaglinide hit fast, biguanides like metformin curb liver glucose. It's a chronic pancreas prod, not a sensitivity or liver play nurses and pharmacists peg it for type 2's insulin lag, a distinct class with a clear job.
A 20 day old neonate born at term is exposed to a child with chicken pox, what intervention should take place?
- A. Give ZIG to all such neonates
- B. Give ZIG depending on mothers serology
- C. Give aciclovir to all
- D. Give aciclovir depending on mothers serology
Correct Answer: B
Rationale: Neonate, 20 days ZIG if mom's seronegative, not blanket or aciclovir guess. Nurses tie this chronic shield to history.
A chemotherapy drug that causes alopecia is prescribed for a patient. Which action should the nurse take to support the patient's self-esteem?
- A. Encourage the patient to purchase a wig or hat to wear when hair loss begins.
- B. Suggest that the patient limit social contacts until regrowth of the hair occurs.
- C. Teach the patient to wash hair gently with mild shampoo to minimize hair loss.
- D. Inform the patient that hair usually grows back once chemotherapy is complete.
Correct Answer: A
Rationale: Alopecia from chemo (e.g., cyclophosphamide) guts self-esteem prepping with wigs or hats hands control back, softening the blow. Limiting contact isolates; gentle washing won't stop it follicles are toast. Regrowth is true but delayed. Nurses in oncology push this proactive step it's practical, empowering, and tackles the psychosocial hit head-on.
The following strategies can be used to help patients overcome the barriers and challenges faced in insulin therapy EXCEPT:
- A. Threaten patient into adherence with insulin therapy
- B. Engage the patient in shared decision-making, select an insulin regimen that they can adhere to
- C. Provide close supervision and follow up when the patient is newly initiated on insulin therapy
- D. Offer measures to reduce weight gain through lifestyle and dietary advice, concomitant use of insulin with metformin, SGLT-2 inhibitors, GLP-1RA
Correct Answer: A
Rationale: Effective insulin therapy strategies include shared decision-making, close supervision at initiation, and weight gain mitigation via lifestyle and adjunctive drugs like metformin all fostering adherence and success. Threatening patients, however, is counterproductive, increasing resistance, anxiety, and non-compliance, contrary to patient-centered care principles. It undermines trust, critical in chronic disease management, where collaboration and support drive outcomes. Physicians must avoid coercive tactics, focusing instead on empowerment and tailored solutions to overcome insulin therapy barriers.